Trials / Completed
CompletedNCT02379559
Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men
An Exercise Intervention on Metabolic Syndrome and Prostate Cancer Risk Among Black Men
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Georgetown University · Academic / Other
- Sex
- Male
- Age
- 40 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to examine the feasibility of an exercise intervention on metabolic syndrome (MetS) components and biomarkers related to prostate cancer in Black men with MetS who are at increased risk of prostate cancer.
Detailed description
The specific aim for the proposed study is to examine the feasibility and impact of a 6-month two-arm randomized controlled trial (RCT) on MetS components and biomarkers related to prostate cancer in Black men with MetS. Due to the striking racial disparities of prostate cancer, this proposal will focus on the impact of an aerobic and resistance exercise intervention on MetS and biomarkers related to prostate cancer in Black men. Specifically, our proposed clinical trial compares an aerobic and resistance exercise intervention to an attention control group among Black men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise | For the first 12-weeks, participants will come to our community based research office for up to 50 min/session, 3-days/week of supervised exercise. Exercise duration will increase from 75 min/wk at week 1 to 150 min/wk by week 4. Thereafter, men will maintain 150 min/wk of moderate-intensity physical activity. |
| BEHAVIORAL | Attention Control | We will provide weekly healthy lifestyle tips via text messages, and will include tips such as managing stressors in life and getting better sleep. |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2017-02-16
- Completion
- 2017-02-16
- First posted
- 2015-03-05
- Last updated
- 2017-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02379559. Inclusion in this directory is not an endorsement.